Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study
- PMID: 35943165
- DOI: 10.1111/hiv.13367
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study
Abstract
Objectives: Our objective was to identify missed opportunities for the use of pre-exposure prophylaxis (PrEP) in people with recently acquired HIV, factors associated with PrEP knowledge, and reasons for not using PrEP.
Design: This was a French national cross-sectional multicentre study enrolling people diagnosed with recent HIV (incomplete Western blot or negative HIV test in the previous 6 months) in 28 HIV clinical centres. Data were gathered using a self-administered questionnaire (SAQ).
Method: We analysed missed opportunities for PrEP use via a retrospective prep cascade. Factors associated with prior knowledge of PrEP and reasons for PrEP non-use among those who knew about PrEP were described using univariate and multivariate logistic regression models.
Results: Of the 224 eligible patients, 185 completed the SAQ and 168 (91%) were eligible for PrEP. Of these, 90% reported seeing at least one physician during the previous year, 26% received information about PrEP, and 5% used PrEP. Factors independently associated with a higher probability of knowing about PrEP were being a man who has sex with men, being aged 25-30 years (vs older), undergoing HIV screening at least once every semester (vs less often; odds ratio [OR] 4.11; 95% confidence interval [CI] 2.00-8.45), and practicing chemsex (OR 3.19; 95% CI 1.12-9.10). Fear of side effects and a low perceived risk of HIV infection were the two most common reasons for not using PrEP (N = 40 [33.33%] and N = 34 [28.3%], respectively).
Conclusions: We found two gaps in the retrospective PrEP cascade: insufficient provision of PrEP information by healthcare providers (mainly general practitioners) and low PrEP acceptability by informed, eligible patients. More diverse healthcare providers need to be involved in PrEP prescription, and at-risk people need to be sensitized to the risk of HIV infection.
Keywords: HIV prevention; HIV testing; PrEP; missed opportunities for uptake; new HIV diagnosis.
© 2022 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.
References
REFERENCES
-
- Lot F, Cazein F, Ndeikoundam N, et al. Infection par le VIH et IST bactériennes. Point épidémiologique du 26 novembre 2018 Institut de veille sanitaire Santé publique France. Nov 26, 2018.
-
- Épidémiologie de l'infection VIH en France. 2013-2018. Tendances et contribution de la prévention combinée (dépistage, traitement antirétroviral des PVVIH, prévention par le préservatif et la PrEP) ANRS; 2020 Jul.
-
- Velter A, Duchesne L, Lydié N. Augmentation du recours répété au dépistage VIH parmi les hommes ayant des relations sexuelles avec des hommes en France entre 2017 et 2019. Résultats de l'enquête rapport au sexe. Bull Epidémiol Hebd. 2019;31-32:648-656.
-
- Dépistage du VIH: état des lieux en 2019 et sur les sept premiers mois de l'année 2020. Bull Epidémiol Hebd. 2020 Dec;33-34:685-687.
-
- Molina J-M, Capitant C, Spire B, et al. On-demand Preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237-2246.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
